A label-free electrochemical affisensor for cancer marker detection: The case of HER2.

In this paper, we report the development of a sensitive label-free impedimetric biosensor based on the use of affibody as bioreceptor and gold nanostructured screen-printed graphite as a sensor platform for the detection of human epidermal growth factor receptor 2 (HER2). The affisensor is realized by immobilizing a terminal cysteine-modified affibody on gold nanoparticles. The sensor was characterized by electrochemical techniques and scanning electron microscopy (SEM). Furthermore, surface plasmon resonance (SPR) technology was also applied to explore the potential of affibodies as small-molecule discriminating tools. Using optimized experimental conditions, a single-use affisensor showed a good analytical performance for HER2 detection from 0 to 40 μg/L. The estimated limit of detection was 6.0 μg/L. Finally, the realized affisensor was applied to human serum samples.

[1]  S. Muyldermans,et al.  Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination. , 2014, Talanta.

[2]  Wanyi Tai,et al.  The role of HER2 in cancer therapy and targeted drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Yang Li,et al.  Electrocatalytic Oxidation of NADH on Graphene Oxide and Reduced Graphene Oxide Modified Screen-Printed Electrode , 2011, International Journal of Electrochemical Science.

[4]  S. Gambhir,et al.  Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. , 2011, Biomaterials.

[5]  Xiaomei Pei,et al.  Sandwich-type immunosensors and immunoassays exploiting nanostructure labels: A review. , 2013, Analytica chimica acta.

[6]  G. Marrazza,et al.  CA 125 Immunosensor Based on Poly‐Anthranilic Acid Modified Screen‐Printed Electrodes , 2013 .

[7]  P. Ugo,et al.  Nanoelectrode ensembles as recognition platform for electrochemical immunosensors. , 2008, Biosensors & bioelectronics.

[8]  Subash C B Gopinath,et al.  Current aspects in immunosensors. , 2014, Biosensors & bioelectronics.

[9]  J M Pingarrón,et al.  Simultaneous detection of two breast cancer-related miRNAs in tumor tissues using p19-based disposable amperometric magnetobiosensing platforms. , 2015, Biosensors & bioelectronics.

[10]  Giovanna Marrazza,et al.  Enzyme-amplified electrochemical hybridization assay based on PNA, LNA and DNA probe-modified micro-magnetic beads. , 2009, Bioelectrochemistry.

[11]  Sridhar Ramaswamy,et al.  Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort , 2008, Clinical Cancer Research.

[12]  Victor Chernomordik,et al.  In Vivo Fluorescence Lifetime Imaging for Monitoring the Efficacy of the Cancer Treatment , 2014, Clinical Cancer Research.

[13]  D. Hayes.  Tumor markers for breast cancer. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  R. O'Regan,et al.  The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy , 2012, Chemotherapy research and practice.

[15]  C. Delerue-Matos,et al.  Electrochemical immunosensor for the analysis of the breast cancer biomarker HER2 ECD. , 2014, Talanta.

[16]  J. Nam,et al.  Electrochemical detection of HER2 using single stranded DNA aptamer modified gold nanoparticles electrode , 2013 .

[17]  Elif Burcu Bahadır,et al.  Applications of electrochemical immunosensors for early clinical diagnostics. , 2015, Talanta.

[18]  N. de-los-Santos-Álvarez,et al.  Impedimetric aptasensor for tobramycin detection in human serum. , 2011, Biosensors & bioelectronics.

[19]  J. Carlsson,et al.  Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line. , 2008, Biochemical and biophysical research communications.

[20]  Li Zhang,et al.  A disposable biosensor based on immobilization of laccase with silica spheres on the MWCNTs-doped screen-printed electrode , 2012, Chemistry Central Journal.

[21]  Giovanna Marrazza,et al.  A New Electrochemical Multiplexed Assay for PSA Cancer Marker Detection , 2011 .

[22]  Jian-hua Zhao,et al.  Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer. , 2004, Cancer letters.

[23]  Mahdi Emami,et al.  An electrochemical immunosensor for detection of a breast cancer biomarker based on antiHER2-iron oxide nanoparticle bioconjugates. , 2014, The Analyst.

[24]  M. Mascini,et al.  Electrochemical bioassay for the detection of TNF-α using magnetic beads and disposable screen-printed array of electrodes. , 2013, Bioanalysis.

[25]  J. Cuzick,et al.  Markers for the identification of late breast cancer recurrence , 2015, Breast Cancer Research.

[26]  Stefan Ståhl,et al.  Engineered affinity proteins--generation and applications. , 2009, Journal of biotechnology.

[27]  G. Marrazza,et al.  An Electrochemical Immunoassay for HER2 Detection , 2012 .

[28]  Giovanna Marrazza,et al.  Electrochemical immunosensors in breast and ovarian cancer. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[29]  Carolina Gutierrez,et al.  HER2: biology, detection, and clinical implications. , 2011, Archives of pathology & laboratory medicine.

[30]  E. Bahadır,et al.  Applications of electrochemical immunosensors for early clinical diagnostics. , 2015 .

[31]  G. Marrazza,et al.  New label free CA125 detection based on gold nanostructured screen-printed electrode , 2013 .

[32]  L. Hutchinson,et al.  Breast cancer: Challenges, controversies, breakthroughs , 2010, Nature Reviews Clinical Oncology.

[33]  James F Rusling,et al.  Designing nanomaterial-enhanced electrochemical immunosensors for cancer biomarker proteins. , 2009, Bioelectrochemistry.

[34]  Giovanna Marrazza,et al.  Disposable genosensor, a new tool for the detection of NOS-terminator, a genetic element present in GMOs , 2004 .

[35]  G. Marrazza,et al.  Aligned carbon nanotube thin films for DNA electrochemical sensing , 2009 .

[36]  Fredrik Y Frejd,et al.  Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications , 2010, FEBS letters.

[37]  S. Gopinath,et al.  Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay. , 2015, Biosensors & bioelectronics.

[38]  J. Rossier,et al.  A new gravity‐driven microfluidic‐based electrochemical assay coupled to magnetic beads for nucleic acid detection , 2010, Electrophoresis.

[39]  Sonia Amaya-González,et al.  Aptamer binding to celiac disease-triggering hydrophobic proteins: a sensitive gluten detection approach. , 2014, Analytical chemistry.

[40]  J. Carlsson,et al.  Tumor imaging using a picomolar affinity HER2 binding affibody molecule. , 2006, Cancer research.